↓ Skip to main content

Comparison the efficacy of suspension and intravenous drip of linezolid for pneumonia

Overview of attention for article published in NIHON KYUKYU IGAKUKAI ZASSHI, January 2014
Altmetric Badge

Mentioned by

twitter
2 tweeters
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison the efficacy of suspension and intravenous drip of linezolid for pneumonia
Published in
NIHON KYUKYU IGAKUKAI ZASSHI, January 2014
DOI 10.3893/jjaam.25.904
Authors

Ryuta Nakashima, Nobuhiro Inagaki

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2015.
All research outputs
#4,451,562
of 6,341,806 outputs
Outputs from NIHON KYUKYU IGAKUKAI ZASSHI
#1
of 1 outputs
Outputs of similar age
#107,895
of 161,004 outputs
Outputs of similar age from NIHON KYUKYU IGAKUKAI ZASSHI
#1
of 1 outputs
Altmetric has tracked 6,341,806 research outputs across all sources so far. This one is in the 26th percentile – i.e., 26% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 0.0. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,004 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them